|
|
|
41
|
3582F
|
SODIUM BICARBONATE 8.4% INJ (KWA) (B)
|
SODIUM BICARBONATE
|
SODIUM BICARBONATE
|
50ML
|
B
|
4.4
|
4.4037
|
VIAL
|
70
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
4008
|
ALKALINIZING AGENTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ALKALINIZING AGENTS
|
|
|
|
|
42
|
3582G
|
SODIUM BICARBONATE 8.4% INJ (KWA)
|
SODIUM BICARBONATE
|
SODIUM BICARBONATE
|
50ML
|
B
|
5.03
|
5.03
|
VIAL
|
70
|
|
KWA
|
KWALITY PHARMACEUTICALS
|
STO
|
BRYDEN STOKES LTD
|
|
4008
|
ALKALINIZING AGENTS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
ALKALINIZING AGENTS
|
2026-03-02
|
|
|
|
40
|
35831
|
SODIUM BICARBONATE 8.4% INJ (FSB/ATB)
|
SODIUM BICARBONATE
|
SODIUM BICARBONATE
|
10ML
|
B
|
1.14
|
1.14
|
INJECTION
|
0
|
VIAL
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
4008
|
ALKALINIZING AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ELECTROLYTIC, CALORIC, AND WATER BALANCE
|
|
|
|
|
41
|
35831
|
SODIUM BICARBONATE 8.4% INJ (FSB)
|
SODIUM BICARBONATE
|
SODIUM BICARBONATE
|
10ML
|
B
|
1.2
|
1.1961
|
VIAL
|
70
|
VIAL
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
4008
|
ALKALINIZING AGENTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ALKALINIZING AGENTS
|
|
|
|
|
42
|
35833
|
SODIUM BICARBONATE 8.4% INJ (FSB)
|
SODIUM BICARBONATE
|
SODIUM BICARBONATE
|
10ML
|
B
|
1.09
|
1.09
|
VIAL
|
70
|
|
FSB
|
FLAGSHIP BIOTECH
|
STO
|
BRYDEN STOKES LTD
|
|
4008
|
ALKALINIZING AGENTS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
ALKALINIZING AGENTS
|
2026-03-05
|
|
|
|
42
|
35861
|
SODIUM BICARBONATE 4.2% INJ (MTP)
|
SODIUM BICARBONATE
|
SODIUM BICARBONATE
|
10X10ML
|
B
|
103.35
|
10.34
|
AMPG
|
0
|
AMP
|
MTP
|
MARTINDALE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
4008
|
ALKALINIZING AGENTS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
ALKALINIZING AGENTS
|
|
|
|
|
40
|
35911
|
LAMICTAL 25MG TAB (GSK/COL) LAMOTRIGINE
|
LAMOTRIGINE
|
LAMICTAL
|
30'S
|
C
|
41.37
|
1.38
|
TABLET
|
0
|
TAB
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
35911
|
LAMICTAL 25MG TAB (GSK) LAMOTRIGINE (C)
|
LAMOTRIGINE
|
LAMICTAL
|
30'S
|
C
|
45.48
|
1.5159
|
TAB
|
60
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
42
|
35911
|
LAMICTAL 25MG TAB (GSK) LAMOTRIGINE
|
LAMOTRIGINE
|
LAMICTAL
|
30'S
|
C
|
47.73
|
1.59
|
TAB
|
60
|
BLIS
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
AVENTA BARBADOS
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
42
|
3591F
|
APO-LAMOTRIGINE 25MG TAB (APO) LAMO
|
LAMOTRIGINE
|
APO-LAMOTRIGINE
|
100'S
|
B
|
10.41
|
0.10
|
TAB
|
60
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
40
|
3591G
|
PMS-LAMOTRIGINE 25MG TAB (PMS/COL)
|
LAMOTRIGINE
|
PMS-LAMOTRIGINE
|
100'S
|
B
|
13.59
|
0.14
|
TABLET
|
0
|
TAB
|
PMS
|
PHARMASCIENCE
|
COL
|
COLLINS LTD
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
3591Q
|
APO-LAMOTRIGINE 25MG TAB (APO) LAMO (B)
|
LAMOTRIGINE
|
APO-LAMOTRIGINE
|
100'S
|
B
|
10.41
|
0.1041
|
TAB
|
60
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
42
|
3591T
|
LEMOGIN 25MG DISP TAB (JLP) LAMOTRIGINE
|
LAMOTRIGINE
|
LEMOGIN
|
20X10
|
B
|
23.11
|
0.12
|
TAB
|
0
|
BLIS
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
40
|
35921
|
LAMICTAL 50MG TAB (GSK/COL) LAMOTRIGINE
|
LAMOTRIGINE
|
LAMICTAL
|
30'S
|
C
|
81.20
|
2.71
|
TABLET
|
0
|
TAB
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
35921
|
LAMICTAL 50MG TAB (GSK) LAMOTRIGINE (B)
|
LAMOTRIGINE
|
LAMICTAL
|
30'S
|
B
|
89.35
|
2.9784
|
TAB
|
60
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
42
|
35921
|
LAMICTAL 50MG TAB (GSK) LAMOTRIGINE
|
LAMOTRIGINE
|
LAMICTAL
|
30'S
|
C
|
98.40
|
3.28
|
TAB
|
60
|
BLIS
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
AVENTA BARBADOS
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
40
|
3592D
|
LAMEZ 50MG TAB (INP/AAL) LAMOTRIGINE
|
LAMOTRIGINE
|
LAMEZ
|
56'S
|
B
|
58.28
|
1.04
|
TABLET
|
0
|
TAB
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AAL
|
A. A. LAQUIS LTD
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
42
|
3592G
|
LEMOGIN 50MG DISP TAB (JLP) LAMOTRIGINE
|
LAMOTRIGINE
|
LEMOGIN
|
20X10
|
B
|
24.46
|
0.12
|
TAB
|
0
|
BLIS
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
40
|
35931
|
LAMICTAL 100MG TAB (GSK/COL) LAMOTRIGINE
|
LAMOTRIGINE
|
LAMICTAL
|
30'S
|
C
|
89.46
|
2.98
|
TABLET
|
0
|
TAB
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
35931
|
LAMICTAL 100MG TAB (GSK) LAMOTRIGINE (C)
|
LAMOTRIGINE
|
LAMICTAL
|
30'S
|
C
|
98.4
|
3.2801
|
TAB
|
60
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|